<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04386629</url>
  </required_header>
  <id_info>
    <org_study_id>20180349</org_study_id>
    <nct_id>NCT04386629</nct_id>
  </id_info>
  <brief_title>Health Economy Register</brief_title>
  <acronym>GeRA</acronym>
  <official_title>Evaluation of CANKADO in Breast Cancer Patients in Germany</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cankado Service GmbH</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cankado Service GmbH</source>
  <brief_summary>
    <textblock>
      In breast oncology, the increasing number of oral and intravenous drug therapies pose great
      challenges for patient management. Numerous studies demonstrate that well-informed patients
      develop higher confidence in their treatment and a greater sense of disease control,
      resulting in increased adherence and persistence as well as potentially better outcome. The
      electronic Patient Reported Outcome (ePRO) tool CANKADO is designed to help oncologists to
      fill the gap between good, personalized care and a time and resource-saving treatment for
      cancer patients. CANKADO helps patients and their physicians regarding therapy management by
      a standardized documentation procedure and, if needed, direct feedback to patients by the
      integrated Pro-React system. GeRA includes patients undergoing systemic therapy for breast
      cancer with access to CANKADO. The trial is based on questionnaires that are answered by
      patients via the CANKADO Patient App. Primary objective is to gain knowledge on the health
      economic impact of CANKADO resource utilization in breast cancer care including the
      evaluation of physicians' time and patient experience.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 5, 2019</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Occasion of consultation</measure>
    <time_frame>3 months</time_frame>
    <description>To obtain the information on the health economic impact of CANKADO resource utilization patients will be asked to fill in a questionnaire containing a question about the occasion of consultation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Frequency of consultation</measure>
    <time_frame>3 months</time_frame>
    <description>To obtain the information on the health economic impact of CANKADO resource utilization patients will be asked to fill in a questionnaire containing a question about the frequency of consultation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Duration of consultation</measure>
    <time_frame>3 months</time_frame>
    <description>To obtain the information on the health economic impact of CANKADO resource utilization patients will be asked to fill in a questionnaire containing a question about the duration of consultation. Also, the time spent for travelling and for the appointment is included here.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life (QoL): Quality of Life Questionnaire (FACT-B)</measure>
    <time_frame>3 months</time_frame>
    <description>Quality of life (QoL) was assessed as part of the Quality of Life Questionnaire (FACT-B) as the subjective feeling of the patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Estimate usage satisfaction of healthcare professionals: minutes</measure>
    <time_frame>3 months</time_frame>
    <description>The usage satisfaction of healthcare professionals was evaluated by assessing the impact on workload of CANKADO assessed in minutes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Age</measure>
    <time_frame>3 months</time_frame>
    <description>Assessed in years</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gender</measure>
    <time_frame>3 months</time_frame>
    <description>Assessed as male/female</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Grade of education</measure>
    <time_frame>3 months</time_frame>
    <description>Assessed as following options: secondary modern school, secondary school, abitur, university degree, promotion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of inhabitants in hometown</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>German home state</measure>
    <time_frame>3 months</time_frame>
    <description>Assessed as: Baden-Württemberg, Bayern, Berlin, Brandenburg, Bremen, Hamburg, Hessen, Mecklenburg-Vorpommern, Niedersachsen, Nordrhein-Westfalen, Rheinland-Pfalz, Saarland, Sachsen, Sachsen-Anhalt, Schleswig-Holstein, Thüringen</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Location of treatment</measure>
    <time_frame>3 months</time_frame>
    <description>Assessed as: university hospital, hospital, haemato-oncologist, gynaecologic oncologist</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Year of primary brest cancer diagnosis</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiotherapy treatment of patient</measure>
    <time_frame>3 months</time_frame>
    <description>assessed as: yes/no</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oral cancer treatment of patient</measure>
    <time_frame>3 months</time_frame>
    <description>assessed as: yes/no</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment of patient with osteopretectics</measure>
    <time_frame>3 months</time_frame>
    <description>assessed as: yes/no</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment of patient against high blood pressure</measure>
    <time_frame>3 months</time_frame>
    <description>assessed as: yes/no</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment of patient against diabetes</measure>
    <time_frame>3 months</time_frame>
    <description>assessed as: yes/no</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment of patient against asthma</measure>
    <time_frame>3 months</time_frame>
    <description>assessed as: yes/no</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>employment status of patient</measure>
    <time_frame>3 months</time_frame>
    <description>assessed as : employed, not employed, retirement</description>
  </secondary_outcome>
  <enrollment type="Anticipated">337</enrollment>
  <condition>Breast Neoplasms</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients under medical treatment for breast cancer with access to CANKADO will be included
        in the analysis. This study will take place in at least 10 German centers with CANKADO
        access / participation representatively distributed in Germany.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men and women with breast cancer

          -  Ongoing medical drug treatment

          -  18 years or older

          -  CANKADO account

        Exclusion Criteria:

          -  Lack of consent to study participation or lack of patient's ability to stuconsent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Timo Schinköthe, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Cankado Service GmbH</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lena-Sophie Fink</last_name>
    <phone>+4922142915300</phone>
    <email>l.fink@cankado.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hämato-onkologischer Studienkreis am Klinikum Aschaffenburg</name>
      <address>
        <city>Aschaffenburg</city>
        <zip>63739</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Kliniken der Stadt Köln - Krankenhaus Holweide, Brustzentrum</name>
      <address>
        <city>Cologne</city>
        <zip>51067</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Kliniken Essen Mitte</name>
      <address>
        <city>Essen</city>
        <zip>45136</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Onkology Bethanien Frankfurt</name>
      <address>
        <city>Frankfurt</city>
        <zip>60389</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Mammazentrum Hamburg Am Krankenhaus Jerusalem</name>
      <address>
        <city>Hamburg</city>
        <zip>20357</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Mainz</city>
        <zip>55131</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Mannheim</city>
        <zip>68167</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>München</city>
        <zip>80377</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Johanna Etienne Krankenhaus</name>
      <address>
        <city>Neuss</city>
        <zip>41462</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Praxisnetzwerk Hämatologie/ intern. Onkologie</name>
      <address>
        <city>Troisdorf</city>
        <zip>53840</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 4, 2020</study_first_submitted>
  <study_first_submitted_qc>May 12, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 13, 2020</study_first_posted>
  <last_update_submitted>May 12, 2020</last_update_submitted>
  <last_update_submitted_qc>May 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

